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O B J E C T I V E S To determine whether catheter-based near-infrared spectroscopy (NIRS) signals
obtained with a novel catheter-based system from coronaries of patients are similar to those from
autopsy specimens and to assess initial safety of NIRS device.
B A C KG ROUND An intravascular NIRS system for detection of lipid core-containing plaques (LCP)
has been validated in human coronary autopsy specimens. The SPECTACL (SPECTroscopic Assessment
of Coronary Lipid) trial was a parallel ﬁrst-in-human multicenter study designed to demonstrate the
applicability of the LCP detection algorithm in living patients.
METHOD S Intracoronary NIRS was performed in patients undergoing percutaneous coronary
intervention. Acquired spectra were blindly compared with autopsy NIRS signals with multivariate
statistics. To meet the end point of spectral similarity, at least two-thirds of the scans were required to
have 80% of spectra similar to the autopsy spectra.
R E S U L T S A total of 106 patients were enrolled; there were no serious adverse events attributed to
NIRS. Spectroscopic data could not be obtained in 17 (16%) patients due to technical limitations, leaving
89 patients for analysis. Spectra from 30 patients were unblinded to test the calibration of the LCP
detection algorithm. Of the remaining 59 blinded cases, after excluding 11 due to inadequate data,
spectral similarity was demonstrated in 40 of 48 spectrally adequate scans (83% success rate, 95%
conﬁdence interval: 70% to 93%, median spectral similarity/pullback: 96%, interquartile range 10%). The
LCP was detected in 58% of 60 spectrally similar scans from both cohorts.
CONC L U S I O N S This intravascular NIRS system safely obtained spectral data in patients that were
similar to those from autopsy specimens. These results demonstrate the feasibility of invasive detection
of coronary LCP with this novel system. (SPECTACL: SPECTroscopic Assessment of Coronary Lipid;
NCT00330928) (J Am Coll Cardiol Img 2009;2:858–68) © 2009 by the American College of Cardiology
Foundation
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859ipid core-containing coronary plaques (LCP),
which are implicated in the progression of coro-
nary atherosclerosis and are thought to be the
cause of most acute coronary syndromes
ACS), cannot be detected by conventional diag-
ostic methods (1,2). A diagnostic modality that
ould detect LCP could be used for improved risk
tratification and as a guide to therapy to prevent
uture cardiovascular events (3).
Near-infrared spectroscopy (NIRS), which is
outinely used in science and industry to determine
he chemical composition of substances, has the
otential to identify LCP in patients (4). Studies
onducted by several groups over the last decade
ave consistently documented the ability of NIRS
o identify lipid core atherosclerotic plaques in
utopsy specimens (5–9). A catheter-based NIRS
ystem suitable for detection of intracoronary LCP
n patients has recently been developed, and its
bility to identify LCP has been validated in a
uman coronary autopsy study (10).
The SPECTACL (SPECTroscopic Assessment
f Coronary Lipid) study was conducted to deter-
ine whether NIRS signals obtained in the coro-
ary arteries of living patients are spectrally similar
o those obtained in the autopsy validation study
Fig. 1) (11). Secondary goals of the study were to
btain evidence supporting the expected safety of
his catheter-based NIRS system and to identify the
revalence of LCP, as detected by NIRS, in coro-
ary arterial segments in living patients.
E T H O D S
IRS system. The NIRS system consists of a 3.2-F
apid exchange catheter, a pullback and rotation
PBR) device, and a console (Fig. 2). The study was
nitiated with a “primed” catheter, which required a
aline flush to prime the imaging window and a
omplex connection to a prototype PBR device. In
he latter portion of the study, a redesigned “sealed”
atheter was used, which obviated the need for
riming and simplified the connection to the PBR
evice.
The system acquires approximately 1,000 NIRS
easurements/12.5 mm of artery scanned. Each
easurement interrogates an area of 1 to 2 mm2 of
umen surface perpendicular to the long axis of the
atheter and centered on the catheter’s optical tip.
he majority of the NIRS tissue information is
btained from a depth of 1 mm or less in the oirection from the luminal surface toward the
dventitia.
The measurement of the probability of LCP for
ach scanned arterial segment is displayed as a map,
ith the x-axis indicating the pullback position in
illimeters and the y-axis the circumferential posi-
ion of the measurement in degrees. The algorithm
isplays the probability of LCP at the interrogation
ite by using a false color scale from red (low
robability) to yellow (high probability). The entire
isplay is termed a chemogram (Fig. 3).
To enhance interpretation of the chemogram, a
ummary metric (the block chemogram) is com-
uted to display the probability that an LCP is
resent for all measurements made in each 2-mm
lock of the pullback (Fig. 3). The block
hemogram provides a summary of the
ata and does not indicate individual pixel
ata or the location of a measurement in
he circumferential dimension.
atient population. Patients were recruited
rom the population undergoing non-
mergent percutaneous coronary interven-
ion (PCI) of a de novo coronary lesion for
table coronary artery disease or ACS at 6
articipating centers. The institutional re-
iew board of each center approved the
tudy. Informed consent was obtained for
ll patients before the procedure.
Patients were excluded if there was
vidence of ongoing ischemia in the pre-
eding 24 h, if more than 2 separate
oronary lesions were to be stented, if the
arget lesion had high-risk characteristics
angulated, length 20 mm, ostial loca-
ion, bifurcation, reference vessel diameter
2.5 mm, angiographic thrombus), or if
here was evidence of renal or liver failure,
nemia, or any major systemic illness.
tudy procedure and image acquisition. The
arget lesion for imaging, which in most cases was
he culprit lesion leading to the need for PCI, was
dentified from the coronary angiogram as per
tandard clinical practice in conjunction with other
ocalizing data obtained by noninvasive testing
hen applicable. Procedures were performed via the
emoral or radial approach at the discretion of the
perator with 6-F or larger standard coronary guid-
ng catheters. After routine anticoagulation, the
arget lesion was crossed with a 0.014-inch guide-
ire. Dilation of the target lesion before NIRS
maging was performed at the discretion of the
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860A safety prerequisite for performing NIRS was
uccessful advancement of a commercially available
ntravascular ultrasound (IVUS) catheter without
vidence of ischemia (chest pain or electrocardio-
raphic changes). After IVUS, scanning NIRS was
erformed in the target vessel. When possible, the
IRS imaging window was positioned beyond the
SPECTACL Clinical St
E
Ex Vivo
Sp
In Vivo Clinical
Spectra
~
~
Figure 1. NIRS System Validation Strategy
Ex vivo study: the lipid core-containing coronary plaques (LCP) dete
reference gold standard and prospectively validated in an independ
(SPECTroscopic Assessment of Coronary Lipid) Clinical Study was de
ies of patients were substantially the same as the spectral features
demonstrate the applicability of the LCP detection algorithm to livi
Figure 2. InfraReDx NIRS System
(A) The portable near-infrared spectroscopy (NIRS) console contains
and a user interface that displays the chemogram of the scanned a
imaging core. (C) The disposable imaging catheter contains the rot
light as well as a sealed outer sheath with a guidewire provision. (D) Oarget lesion. Scanning NIRS with automated ro-
ational pullback was then performed at a speed of
.5 mm/s and 240 RPM with the goal of terminat-
ng the pullback after the imaging element entered
he guiding catheter. The NIRS catheter was re-
oved, and the rest of the PCI procedure contin-
ed as planned. Angiographic data were stored
y
Vivo Autopsy Study
topsy
ra Histology=
n algorithm was trained from ex vivo spectra with histology as a
set of coronaries from human autopsy hearts (10). The SPECTACL
ed to show that the spectral features of data acquired in coronar-
e ex vivo study. Similarity of in vivo and ex vivo spectra would
atients. NIRS  near-infrared spectroscopy.
laser light source, a computer for algorithmic data processing,
. (B) The pullback and rotation device rotates and pulls back the
core with optical ﬁbers that deliver and collect near-infraredud
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861igitally for subsequent analysis. The NIRS data
nalysis was performed offline on the prospectively
ollected data.
Post-procedure myocardial infarction (MI) was
efined as creatine kinase (CK) elevation 2 times
ormal with elevated CK-MB fraction and isch-
mic symptoms or re-elevation of CK within 24 h
f the procedure of at least 50% above the previous
evel in ACS patients. An independent Data and
afety Monitoring Board (Appendix) reviewed all
ertinent data at appropriate intervals.
tudy end points. The primary end point of the
tudy was the similarity of NIRS spectra obtained in
atients to spectra previously obtained and validated
y histology in autopsy specimens. Secondary end
oints were to obtain data supporting the expected
afety of the device and to quantify the presence of
CP at target and nontarget sites.
alidation of the LCP detection algorithm in human
oronary artery autopsy specimens. The LCP detec-
ion algorithm was developed and prospectively
alidated in a human coronary artery autopsy study
10). As reported, LCP of interest was defined as
broatheroma 60° in circumferential extent and
200 m in thickness on a cross-sectional histo-
ogic specimen, with a fibrous cap having a mean
hickness of 450 m. The NIRS identified local-
zed LCP with an area under the receiver-operating
Figure 3. A NIRS Scan From a Coronary Artery From the Autops
(Top) False color map of the artery wall indicating the probability o
location along the length (x-axis, in mm) and circumference (y-axis,
high probability). This display is termed a “chemogram.” (Middle) S
egories, termed a “block chemogram,” (Bottom) Russell-Movat’s pen
mm, respectively, along the scanned artery (white rectangles). Ima
detected from 38 to 42 mm, occupying approximately 180° of circu
nals extend from 38 to 41 mm. The near-infrared spectroscopy (NIR
presence of diffuse plaque, which is conﬁrmed by histology.haracteristic curve of 0.80 (95% confidence interval nCI]: 0.76 to 0.85) in vessels 3.0 mm in diameter or
ess (10).
ssessment of frequency and distribution of LCP in
atients in the SPECTACL study. Each chemogram
rom the SPECTACL dataset was evaluated for the
resence of LCP. An LCP was considered to be
resent if at least 1 2-mm segment in the block
hemogram had a strong positive reading (95%
pecificity that LCP is present) as signaled by a
right yellow color.
The prevalence of LCP at the target lesion was
lso calculated in patients in whom the target lesion
ould be located in the chemogram. Registration of
hemographic and angiographic data was obtained
y the following 4-step process. First, the target
esion was located by quantitative coronary angiog-
aphy (QCA) according to the minimum lumen
iameter (MLD). Second, the distance from the
LD to the distal edge of the guide catheter was
alculated with the angiogram with the NIRS
atheter positioned across the target lesion. Third,
he location of the distal edge of the guide catheter
n the chemogram was identified. Fourth, with the
istal edge of the guide catheter serving as the
ducial point, the location of the MLD in the
hemogram was determined according to the dis-
ance calculated in step 2. The length of the target
esion was determined by QCA.
In the few cases in which the 4-step process could
tudy Compared With Histology
lipid core-containing coronary plaques (LCP) of interest at each
egrees) of the scanned artery (red  low probability; yellow 
ary of the presence of LCP at 2-mm intervals in 4 probability cat-
hrome-stained cross-sections (5-m thick) at 8, 18, 28, and 40
terpretation: in the chemogram, a prominent LCP signal is
rence. The block chemogram shows that the strongest LCP sig-
ignals at 28, 18, and 8 mm indicate absence of LCP, despite they S
f a
in d
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ge in
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S) sot be followed, alternative approaches were taken.
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862n the case of missing guide catheter location
NIRS pullback did not contain data from the guide
atheter or the stable positioning of the guide
atheter could not be verified by angiography), the
ocation of the start of the NIRS measurement was
sed as the fiducial point. With this registration
ethod, the distance from the MLD to the starting
osition of the imaging core of the NIRS catheter
n a cine-angiographic frame was calculated, and
his distance was then projected onto the chemo-
ram. In the case of missing guide catheter location
nd starting NIRS position, a combination of
arkers in the chemogram entered by the physician
uring the pullback (side-branches by angiography)
nd fiducial points by IVUS (side-branches) were
sed to determine the location of the MLD in the
hemogram. In all cases, angiographic or IVUS
easurements were performed blinded to the che-
ogram results by a core lab (Montreal Heart
nstitute).
tatistical analysis. ASSURANCE OF THE QUALITY OF
PECTRAL DATA. The first step in analysis of the
imilarity end point was to exclude data of inade-
uate quality, which can result from both instru-
ent and biological causes. Instrument causes in-
lude a poor connection between the catheter and
he PBR device, microscopic debris on the optical
ber faces, damaged optical fibers, system malfunc-
ion, or obstructions such as the guide wire, guide
atheter, stent, or bubbles in the saline solution of
rimed catheters. Biological causes include exces-
ive blood depth encountered in large arteries and
eatures that can cause disturbances in the flow of
lood such as sudden changes in lumen diameter or
rientation, side-branches, or thrombi.
Inadequate spectra excluded before assessment of
pectral similarity were: 1) spectra collected at
ocations in which the guide wire obstructed the
rterial wall; 2) spectra collected when the optical
ip was inside the guide catheter; 3) spectra flagged
y an oscillation metric; and 4) spectra flagged by a
etric indicating poor visibility of the wall due to
xcessive blood depth.
The oscillation metric measures the amount of
scillation in a spectrum as a function of wave-
ength, determined by the sum of squared differ-
nces between a smoothed and unsmoothed version
f the spectrum across wavelengths. The threshold
as determined from analysis of phantom, ex vivo,
nd in vivo spectra with known interferences (bub-
les, flow disturbances, and the like). This metric
dentified spectra that had excessive noise due to
nstrument or biological causes such as those listed sn the preceding text. The wall visibility metric
stimates the depth of blood between the catheter
nd arterial wall present in each spectrum and is
ased on a linear regression model correlating
IRS spectral absorbance with distance to the
rterial wall. The model was constructed from data
ollected in autopsy specimens with lumen contours
rom histology as a reference. The wall was consid-
red no longer sufficiently visible when the distance
o the wall exceeded 3 mm through blood. This
etric determined whether the arterial wall signal
as detectable or whether there was too much
ntervening blood between the wall and catheter
ttenuating the probing light. Inadequate spectra by
hese metrics were excluded before assessment of
pectral similarity.
PECTACL STUDY PRIMARY END POINT—ANALYSIS
F SIMILARITY BETWEEN CLINICAL AND AUTOPSY
PECTRA. Spectra identified as adequate were then
ssessed for similarity with autopsy spectra from the
CP algorithm calibration set with the use of 2
ultivariate metrics: the Mahalanobis distance
MD), and the spectral F-ratio (SFR). The MD is
measure of the covariance-weighted distance be-
ween a point and the center of a set of points. For
validation spectrum x (in vivo) and the mean y of
set of calibration spectra (ex vivo), the MD metric
s given by (in squared units):
MD  x  y' S1 x  y
here S1 is the inverse of the covariance matrix of
he calibration set. Spectra are first projected from
igh- to low-dimensional space by partial least-
quares regression, such that x and y represent
cores in the projection space.
The SFR is the sum of squared residuals of the
alidation spectrum relative to the average sum of
quared residuals of the calibration set. The spectral
esidual is the difference between the estimated
pectrum constructed in a lower dimensional pro-
ection space spanned by the model and the actual
easured spectrum. For spectral residuals eval and
cal corresponding to the validation and calibration
pectra, respectively, the SFR is given by:
SFR  m
k1
n
eval k
2  ⁄ 
i1
m

k1
n
ecal i,k
2 
or m calibration spectra and n wavelengths in a
pectrum.
The technical adequacy of the data was as-
essed for each pullback of varying length. This
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863as accomplished by subdividing a pullback into
ontiguous 2-mm blocks and evaluating each for
pectral adequacy. A block was judged to be
pectrally adequate if 75% of the spectra within
he block were spectrally adequate. A pullback, in
urn, was determined to be spectrally adequate if
75% of the blocks within the pullback were
pectrally adequate. This approach to evaluating
ata quality was similar to that used in the
utopsy validation study (10).
A pullback was judged similar (i.e., a success) if at
east 80% of the spectrally adequate spectra in the
ullback were below the thresholds for both the
D and SFR metrics established during the au-
opsy calibration study and fixed before validation.
The objective of the study was to demonstrate
hat more than two-thirds of the adequate pullbacks
rom patients were spectrally similar to the spectral
eatures observed in the autopsy calibration set. The
ull and alternative hypotheses, respectively, were:
H0: p  0.67
Ha: p  0.67
here p is the proportion of pullbacks (1 pullback/
atient) deemed a success by the spectral similarity
easure. The study was considered to be a success
f the null hypothesis was rejected with the lower
5% CI 0.67 (2-sided test for a binomial distri-
ution, p  0.05).
The frequency of LCP was compared between
roups with a chi-square test. A p value 0.05 was
equired for statistical significance.
Statistical analysis was performed by 2 of the
uthors (S.T.S., M.J.H.). The authors had full
ccess to the data and take responsibility for its
ntegrity. All authors have read and agree to the
anuscript as written.
E S U L T S
total of 106 patients were enrolled in the study,
hich was conducted between January 2006 and
ctober 2007. The demographic and baseline clin-
cal and angiographic characteristics of the study
roup are summarized in Table 1. There were no
ajor adverse events related to NIRS imaging.
The NIRS spectra were obtained in 89 (84%) of
06 patients. No data were acquired in 17 patients
16 with the primed catheter, 1 with the sealed
atheter) due to instrument-related issues or the
nability to cross the lesion with either the IVUS or
he NIRS catheters. The reasons for missing or wechnically inadequate NIRS data are presented in
able 2. Figure 4 provides a summary of the
istribution of patients at each step in the analysis.
In those in whom data were collected, the mean
ullback length was 54.4  22.8 mm (range 13.6 to
16.2 mm). One patient experienced chest pain
uring both IVUS and NIRS imaging, which was
ttributed to temporary occlusion of the vessel by
ositioning of the devices across a narrow stenosis.
he chest pain promptly resolved each time after
emoval of the catheter. Six of 97 (6%) patients in
hom the device was actually inserted into the
oronary artery experienced a periprocedural MI
mean CK-MB elevation 33.1 ng/ml). In 5 of these
ases, the MI was attributed to occlusion of a side
ranch associated with stenting of the target vessel;
n the remaining case, the MI was attributed to
cclusion of a side branch associated with stenting
n a nontarget vessel in which the NIRS catheter
Table 1. Demographic, Clinical, and Angiographic Characteristic
Study Patients
Characteristic
Age, mean  SD, yrs 61
Gender, male, n (%)
Clinical history, n (%)
Hyperlipidemia
Hypertension
Diabetes mellitus
Prior MI
Prior PCI
Coronary artery bypass graft
Cerebral vascular accident/transient ischemic attack
Peripheral vascular disease
Family history of coronary artery disease
Congestive heart failure
Clinical presentation, n (%)
Post MI
Unstable angina
Stable angina
Positive functional study
Atypical chest pain
Congestive heart failure
Other (nonacute coronary syndrome)
Target vessel, n (%)
RCA
LAD
LCX
Mean target lesion diameter stenosis (%  SD) 62
N  106.
LAD  left anterior descending artery; LCX  left circumﬂex artery; MI 
infarction; PCI  percutaneous coronary intervention; RCA  right coronary ars of the
.1  10.0
86 (81)
80 (75)
81 (76)
26 (25)
18 (17)
33 (31)
3 (3)
0 (0)
4 (4)
48 (45)
6 (6)
15 (14)
10 (9)
39 (37)
26 (25)
9 (8)
1 (1)
6 (6)
44 (42)
40 (38)
22 (21)
.5  9.3
myocardial
tery.as not introduced. Distal embolization, no-reflow,
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rotation; SPECTACL  SPECTroscopic Assessment of Coronary Lipid trial.
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864nd thrombus formation were not seen in the
maged target vessels.
rimary end point. Of the 89 patients in whom
IRS spectra were obtained, data from 30 patients
selected from the first patients studied in each
enter) were unblinded to determine whether the
ransition from ex vivo to in vivo measurement
equired modification of the algorithm (11). Review
f the 30 unblinded chemograms indicated that in
ivo spectra would not be needed to augment the
alibration (autopsy) set and that the outlier thresh-
lds selected on the basis of the autopsy data were
dequate for assessment of the in vivo data. The
linded, prospective test of the primary end point
as performed in the remaining cohort of 59
atients (Fig. 4).
Among the 59 patients in the blinded set, 48
81%) had pullbacks of adequate spectral quality as
rospectively specified in the Methods section.
riteria for spectral similarity were satisfied in 40 of
he 48 spectrally adequate pullbacks, resulting in an
3% success rate (95% CI: 70% to 93%), thus
atisfying the primary end point of the study. The
edian spectral similarity for each pullback was
6% with an interquartile range of 10%. Figures 5A
nd 5B provide graphic representations of the
imilarity of clinical and autopsy measurements.
revalence of LCP signal. An exploratory analysis of
he prevalence of LCP signal was performed in the
0 pullbacks that met criteria for spectral adequacy
nd spectral similarity (40 in the blinded group, 20
n the unblinded group). The overall prevalence of
CP in scanned segments was 58% (35 of 60
atients).
The prevalence of LCP at target lesion sites was
alculated in 57 patients in whom the target lesion
as imaged. The prevalence of LCP at identifiable
arget lesions was 42% (24 of 57 patients) (Fig. 6).
re-dilation of the target lesion was performed in
2% (24 of 57 patients). Lipid core-containing
oronary plaque was detected in 50% (12) of pre-
ilated lesions and in 36% (12 of 33) of non–pre-
ilated lesions. Nontarget LCP was observed in
3% of scanned segments (19 of 57 patients) (Fig.
). On the basis of the CASS (Coronary Artery
urgery Study) classification, the location of the
arget lesion sites was proximal, mid, or distal in
5% (n  14), 63% (n  36), and 12% (n  7) of
atients, respectively. Among the 24 target lesion
ites with LCP, 17% (n  4) were proximal, 67%
n  16) were mid, and 17% (n  4) were distal.
atients were subdivided into ACS and non-ACSSPECTACL Study
106 enrolled
Blinded
59
Unblinded
30
Data
89
Technically inadequate
8
Technically inadequate
11
Technically adequate
48
Spectrally Similar
40 of 48
No Data
17
Figure 4. Final Patient Breakdown in the SPECTACL Study
No data were acquired in 17 of 106 patients enrolled, mostly due to instru-
ment-related issues or the inability to cross the lesion with either the intra-
vascular ultrasound or the near-infrared spectroscopy catheters. Collected
data were technically inadequate in 19 of the remaining 89 patients, due to
the reasons enumerated in Table 2. The primary end point was analyzed in
the 48 blinded pullbacks that had technically adequate data. The frequency
of lipid core-containing coronary plaques was examined in the 40 spectrally
similar pullbacks from the blinded group and the 20 spectrally similar pull-
backs from the unblinded group (not shown in the graph). SPECTACL Table 2. Reasons for Missing or Technically Inadequate NIRS Data
in the SPECTACL Study Population
No. of Patients
(n  36)
Missing data
Inability to track vessel with IVUS or NIRS catheter 7
Lack of signal from NIRS catheter 4
Console setup error 2
Jammed PBR 1
Improperly assembled accessory 1
Improper catheter handling 1
Incomplete catheter connection 1
Technically inadequate data
Instrumental causes
Obstructions: guide wire, guide catheter, stent,
bubbles in saline of primed catheters
5
Poor connection between catheter and PBR 4
Microscopic debris on optical ﬁber faces 2
Damaged optical ﬁbers 1
System malfunction 1
Biological causes
Features causing disturbances in blood ﬂow:
sudden changes in lumen diameter or orientation,
side-branches, thrombi
5
Excessive blood depth in large arteries 1
IVUS  intravascular ultrasound; NIRS  near-infrared spectroscopy; PBR  pullback androups on the basis of troponin and CK levels.
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865pecifically, patients with elevated CK (CK 180
/l) or troponin levels (T 0.1 or I 0.4 ng/ml)
ere designated as ACS. Among the 57 patients in
hom the target lesion was imaged, the prevalence
f LCP was 53% (9 of 17) for ACS and 38% (15 of
0) for non-ACS patients (p  0.28).
I S C U S S I O N
his first-in-human study demonstrates that this
atheter-based system can safely perform NIRS in
oronary arteries of living patients. The system
btained high-quality spectra through blood and
uring cardiac motion with short scanning acquisi-
ion times. Analysis of the blinded dataset demon-
trates that the spectra obtained from patients are
imilar to previously validated autopsy spectra,
hereby supporting the applicability of the chemo-
etric algorithm for detection of LCP to patients.
he algorithm identified LCP in a significant
umber of imaged segments in patients undergoing
CI for stable angina and ACS.
afety of the system. No significant intraprocedural
omplications were noted, as expected from the
haracteristics of the catheter, which is similar in
esign and use to existing IVUS catheters. The
bserved 6% rate of post-procedure MI was within
he reported rates (5% to 30%) for patients under-
oing PCI (12–14) and was not likely related to the
se of the device. Thus, no safety concerns were
aised in this relatively low-risk population.
erformance of the catheter-system. Instrument-
elated issues prevented data acquisition in some
atients. Most of these difficulties resulted from
ack of signal from the catheter or operational
rrors. These issues were most frequently observed
ith the first-generation system and catheter and
irtually eliminated with the adoption of the
econd-generation system, which simplifies the
onnection between catheter and PBR and uses a
ealed catheter, which removes the need for
riming.
Inadequate NIRS data that led to exclusion of
ullbacks or failed spectral similarity metric resulted
rom either malfunction of the research device or
he presence of signals not interpretable by the
lgorithm. Examples of the first category include
mproper optical connections or impeded rotation
f the optical core, as would result from overtight-
ning of a hemostatic valve around the catheter.
easons for the algorithm not being able to inter-
ret a signal include: 1) the potential effect of
isturbed blood flow, such as would be seen in the wresence of a side branch in a tight stenosis at a
oint of significant curvature, which can cause
xcessive oscillations in the NIRS spectra; 2) poor
Figure 5. Spectral Similarity of Clinical and Autopsy Measureme
(A) Percent similarity of spectrally adequate pullbacks. Dashed line
median percent similarity (96%). Solid line is 80% minimum thresho
deﬁning a spectrally similar pullback. Forty of the 48 pullbacks (83%
percent similarity above the threshold. Percent similarity is deﬁned
percentage of spectra in a pullback that are within both the Mahal
distance (MD) and spectral F-ratio (SFR) metric thresholds. Similarity
culated between spectra measured in patients and calibration spec
lected in autopsy hearts. (B) Scatterplot of MD and SFR metrics for
individual spectra in the autopsy calibration (blue) and patient data
The plot shows the scatter of the 2 metrics, MD and SFR, used to a
similarity of spectra collected in patients to those collected in autop
mens. Box shows similarity thresholds established during the autop
bration study for the 2 metrics. Axes were scaled to exclude the to
the most extreme outliers for data point visibility. Both metrics of a
spectrum were required to be below their respective thresholds (i.e
the box) for the spectrum to be labeled as similar. Percent similarit
given pullback was deﬁned as the percentage of adequate spectra
pullback whose MD and SFR metrics were both within the threshol
the approximately 177,000 patient spectra, 89% fell within the thrents
is
ld for
) had a
as the
anobis
was cal-
tra col-
(red).
ssess the
sy speci-
sy cali-
p 1% of
given
., inside
y for a
in the
ds. Ofall visibility due to excessive blood depth between
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866Figure 6. NIRS Scan of a Patient and Corresponding Angiogram
(Top) cineangiographic frame of the left coronary artery of a 71-year-old man with post-infarct angina. There is a severe culprit stenosis
(A) in the proximal left anterior descending artery. (Bottom) the corresponding chemogram reveals a prominent, circumferential lipid
core-containing coronary plaques (LCP) signal between 8 and 18 mm in the area of the culprit lesion. The narrowest area of luminal ste-
nosis is approximately 14 mm and demarcated in the chemogram (A). The block chemogram shows that the strongest LCP signals
extend from 9 to 17 mm. NIRS  near-infrared spectroscopy.Figure 7. NIRS Scan of a Patient and Corresponding Angiogram
(Top) cineangiographic frame of the right coronary artery of a 68-year-old man with unstable angina. There is a severe, irregular culprit
stenosis in the mid portion of the artery (B). (Bottom) the corresponding chemogram reveals a prominent lipid core-containing coronary
plaques (LCP) signal between 25 and 31 mm that co-localizes with the culprit stenosis. There are 2 more proximal LCP signals between
43 and 58 mm (A), which probably correspond to a single plaque mass in an “angiographically normal” segment of the vessel. The block
chemogram shows the strongest LCP signals between 26 to 31 mm, 45 to 47 mm, and 51 to 57 mm. NIRS  near-infrared spectroscopy.
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867he catheter and 1 side of the vessel wall, in which
he algorithm would classify such signals as unin-
erpretable (inadequate data); and 3) the presence of
ther unknown biologic or nonbiologic signals,
uch as spectra from a large intraluminal thrombus.
n such cases the spectra might not be recognized
y the algorithm, which was trained on a calibration
et without such features.
It is likely that these technical limitations will be
vercome as more experience is gained with the
evice in a variety of clinical situations and coronary
ubstrates. These issues notwithstanding, the pri-
ary end point of demonstrating spectral similarity
etween ex vivo and in vivo data was achieved.
revalence of LCP in patients. The relatively high
revalence of LCP signals in the chemograms in
he scanned segments (58%) is likely reflective of
he high pretest probability of lipid core plaque in
hese patients (all of whom required PCI) and
elective inquiry at target sites.
There are factors that could have affected the
bserved prevalence of LCP at the target lesion site.
n some cases, the lipid core content of the target
esion might be underestimated before measure-
ent due to some of the lipid being “washed away”
fter plaque rupture. It is also possible that some
arget lesions that ruptured or were dilated retain
ipid that is below the current threshold required for
isplay of an LCP signal on the chemogram. The
CP() signal, indicated by yellow in the chemo-
ram, is displayed when the algorithm indicates
here is a high probability (0.6 on a scale of 0 to
.0 for each pixel) of the presence of an LCP of
nterest. Therefore, if a lipid signal is present but
ess intense (probabilities 0.6 for LCP but 0),
he chemogram is designed to display a red color. A
edicated study of lesion composition could use
hese subthreshold lipid signals.
Situations can also be encountered in which
hemogram signals might differ from histologic
ndings. In the autopsy validation study, Gardner
t al. (10) reported that false positive readings could
e caused by fibroatheromas too small or with caps
oo thick to meet criteria for LCP of interest or by
esions such as intimal xanthoma and pathological
ntimal thickening that contain significant lipid but
o not have necrotic cores. False negative readings,
y contrast, could be produced by necrotic cores
ith extensive calcification or from signals obtained
n a large arterial lumen in which blood obscures the
ipid signal. Both false positives and false negatives
an be created by the need to impose a binary 0efinition (lipid core plaque of a certain size present
r absent) on a continuous variable.
Near-infrared spectroscopy could be used in a
uture study to compare the composition of culprit
esions among patient subgroups of interest. Such a
tudy would require precise definition of the sub-
roups (ACS vs. non-ACS), acquisition of NIRS
ignals before dilation of the lesion in as many
atients as possible, and larger numbers of patients.
tudy limitations. The first-generation NIRS clini-
al system caused an unacceptably high rate of
ailure to obtain adequate data. Much of this
roblem was solved by introduction of the sealed
atheter with the improved connector. However, in
ome instances the new system also generated
ninterpretable or technically inadequate data. The
ources of some of these unknown signals are
iscussed in the preceding text and require further
nvestigation. The lack of repeatability data is a
imitation of our study, because repeat pullbacks
ere not allowed as per protocol. Further studies in
atients will be required to address this issue.
The correlation with a given histologic feature
s not perfect, as is typical for an imaging device.
ven though this device is effective for detection
f LCP of interest as defined, further study will
e required to assess its capability for detection of
ther histologic findings, such as smaller lipid
laques, thrombus, intraplaque hemorrhage, or
nflammation. It is possible that use of molecular
argeting agents or combination imaging technol-
gies will enhance the diagnostic accuracy of the
ystem. Lastly, the clinical utility of identification
f the presence of LCP requires further study. A
rospective follow-up study is planned in which
he relationship between the identification of a
ipid-core plaque and subsequent coronary events
ill be determined.
ummary. High-quality NIRS signals, similar to
hose validated in human coronary autopsy speci-
ens, were obtained from the coronary arteries of
iving patients through blood and during cardiac
otion with a catheter-based system. This first-in-
uman study supports the use of intracoronary
IRS for detection of lipid core plaques in patients
ndergoing PCI. This novel diagnostic capability
as the potential to improve multiple aspects of the
iagnosis and treatment of patients with coronary
rtery disease.
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he members of the Data and Safety Monitoring
oard (DSMB) were John A. Bittl, MD (Munroe
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ames M. Ware, PHD (Harvard School of Public
ealth, Boston, MA). The purpose of the DSMB
as to provide general oversight of the study,
ncluding reviewing the overall protocol, moni-
oring patient safety, and assessing the integrityf the data and results.
